We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

73 hedge funds and large institutions have $474M invested in GenMark Diagnostics, Inc in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 12 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 12

67% more capital invested

Capital invested by funds: $285M → $474M (+$190M)

0% more funds holding

Funds holding: 7373 (0)

0% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 14

77% less call options, than puts

Call options by funds: $6K | Put options by funds: $26K

Holders
73
Holders Change
Holders Change %
0%
% of All Funds
2.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
38
Reduced
12
Closed
14
Calls
$6K
Puts
$26K
Net Calls
-$20K
Net Calls Change
+$22K
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$1.99M +$489K +45,583 +38%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.74M +$286K +26,636 +23%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$1.66M +$1.46M +136,638 New
TCIM
29
TIAA CREF Investment Management
New York
$1.64M +$177K +16,510 +14%
BIM
30
BlackRock Investment Management
Delaware
$1.21M +$257K +23,932 +32%
WMSA
31
Weiss Multi-Strategy Advisers
New York
$1.09M +$965K +90,000 New
KIA
32
Kopp Investment Advisors
Minnesota
$992K -$157K -14,676 -15%
IGIM
33
I.G. Investment Management
Manitoba, Canada
$981K +$127K +11,857 +17%
Charles Schwab
34
Charles Schwab
California
$947K +$202K +18,810 +32%
CCI
35
Columbus Circle Investors
$905K -$906K -84,483 -53%
TD Asset Management
36
TD Asset Management
Ontario, Canada
$898K +$144K +13,400 +22%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$795K +$117K +10,900 +20%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$779K +$144K +13,400 +26%
HCMT
39
Highland Capital Management (Texas)
Texas
$774K +$683K +63,728 New
TA
40
Teachers Advisors
New York
$502K +$26.6K +2,485 +6%
MWNA
41
Marshall Wace North America
New York
$496K +$438K +40,830 New
Morgan Stanley
42
Morgan Stanley
New York
$463K -$355K -33,162 -47%
NFA
43
Nationwide Fund Advisors
Ohio
$347K +$206K +19,256 +207%
U
44
UBS
Switzerland
$318K -$50.5K -4,707 -15%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$314K +$3.02K +282 +1%
GA
46
Geneva Advisors
Illinois
$310K +$148K +13,835 +118%
MLICM
47
Metropolitan Life Insurance Company (MetLife)
New York
$304K +$4.12K +384 +2%
AllianceBernstein
48
AllianceBernstein
Tennessee
$285K -$7K -653 -3%
AQR Capital Management
49
AQR Capital Management
Connecticut
$284K +$251K +23,394 New
VOYA Investment Management
50
VOYA Investment Management
Georgia
$277K

GNMK Hedge Fund Activity: Q3 2013 in Review

73 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2013, worth a combined $474M — up 67% from $285M a quarter earlier.

Fund positioning in GNMK was balanced in Q3 2013: 14 funds opened new positions, 14 closed out, 38 added to existing stakes and 12 trimmed.

The largest buyer was Putnam Investments, adding an estimated $33.2M. The largest seller was BlackRock Advisors, cutting an estimated $6.45M.

  • 73 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $474M of GenMark Diagnostics, Inc stock for Q3 2013, up 67% quarter-over-quarter.
  • 14 funds opened new GenMark Diagnostics, Inc positions in Q3 2013 and 14 closed out, a net change of 0 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q3 2013 was Putnam Investments, an estimated $33.2M added.
  • The largest GenMark Diagnostics, Inc seller in Q3 2013 was BlackRock Advisors, an estimated $6.45M sold.

Based on aggregated 13F filings for Q3 2013.